NVAX
Novavax Inc
Price:  
8.82 
USD
Volume:  
1,962,129.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax WACC - Weighted Average Cost of Capital

The WACC of Novavax Inc (NVAX) is 7.6%.

The Cost of Equity of Novavax Inc (NVAX) is 8.00%.
The Cost of Debt of Novavax Inc (NVAX) is 5.50%.

Range Selected
Cost of equity 7.00% - 9.00% 8.00%
Tax rate 0.20% - 0.50% 0.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.5% - 8.7% 7.6%
WACC

Novavax WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 9.00%
Tax rate 0.20% 0.50%
Debt/Equity ratio 0.16 0.16
Cost of debt 4.00% 7.00%
After-tax WACC 6.5% 8.7%
Selected WACC 7.6%